March 2012
Volume 53, Issue 14
Free
ARVO Annual Meeting Abstract  |   March 2012
Somatostatin Receptor Scintigraphy In Ocular Sarcoidosis
Author Affiliations & Notes
  • Lieke Kamphuis
    Clinical Immunology, Clinical Immunology,
    Erasmus University Medical Center, Rotterdam, The Netherlands
  • Dik J. Kwekkeboom
    Nuclear Medicine, Immunology,
    Erasmus University Medical Center, Rotterdam, The Netherlands
  • Tom Misotten
    The Rotterdam Eye Hospital, Rotterdam, The Netherlands
  • Jan A. van Laar
    Clinical Immunology, Clinical Immunology,
    Erasmus University Medical Center, Rotterdam, The Netherlands
  • Willem A. Dik
    Nuclear Medicine, Immunology,
    Erasmus University Medical Center, Rotterdam, The Netherlands
  • Robert W. Kuijpers
    Ophthalmology,
    Erasmus University Medical Center, Rotterdam, The Netherlands
  • G S. Baarsma
    The Rotterdam Eyehospital, Rotterdam, The Netherlands
  • P M. van Hagen
    Clinical Immunology, Clinical Immunology,
    Erasmus University Medical Center, Rotterdam, The Netherlands
  • Footnotes
    Commercial Relationships  Lieke Kamphuis, None; Dik J. Kwekkeboom, None; Tom Misotten, None; Jan A. van Laar, None; Willem A. Dik, None; Robert W. Kuijpers, None; G. S. Baarsma, None; P. M. van Hagen, None
  • Footnotes
    Support  None
Investigative Ophthalmology & Visual Science March 2012, Vol.53, 3091. doi:
  • Views
  • Share
  • Tools
    • Alerts
      ×
      This feature is available to authenticated users only.
      Sign In or Create an Account ×
    • Get Citation

      Lieke Kamphuis, Dik J. Kwekkeboom, Tom Misotten, Jan A. van Laar, Willem A. Dik, Robert W. Kuijpers, G S. Baarsma, P M. van Hagen; Somatostatin Receptor Scintigraphy In Ocular Sarcoidosis. Invest. Ophthalmol. Vis. Sci. 2012;53(14):3091.

      Download citation file:


      © ARVO (1962-2015); The Authors (2016-present)

      ×
  • Supplements
Abstract

Purpose: : Sarcoidosis is a multisystemic granulomatous immune mediated inflammatory disorder of unknown etiology. It can affect any organ in various degrees of severity. With somatostatin receptor scintigraphy (SRS) sarcoid granulomas can be visualized because of their overexpression of somatostatin receptors. In this study we investigated the extend of disease in patients with ocular sarcoidosis and correlated scintigraphy patterns with biochemical disease parameters.

Methods: : The localization of sarcoid associated lesions and the degree of intensity of uptake of radionuclide coupled octreotide in 119 patients with ocular sarcoidosis were determined. The degree of intensity was compared with serum angiotensin converting enzyme (ACE) and serum soluble interleukin-2 receptor (sIL-2R). Typical patterns on SRS were compared to conventional chest CT and -X-ray.

Results: : SRS was negative in 7 patients, 1 patient had uptake restricted to the eyes and 101 patients had more sarcoidosis associated lesions.The degree of intensity correlated significantly with ACE (p<0.0001) and sIL-2R levels (p<0.0001). Mediastinal lesions together with either eye, salivary glands, clavicular or hilar localizations on SRS demonstrated a significant characteristic pattern. All patients with abnormal conventional diagnostic investigation were SRS positive. Moreover, of 56 patients with normal radiological findings 27 (48%) expressed pathological SRS uptake. In 19 of these 27 patients a lung biopsy was taken, which confirmed sarcoidosis in 15 patients.

Conclusions: : Ocular sarcoidosis is frequently associated with other localizations of sarcoidosis. The degree of intensity in SRS correlates well with sarcoidosis activity. SRS is more sensitive in diagnosing sarcoidosis localizations, even in patients with normal chest radiology. SRS therefore provides a useful and sensitive imaging technique to determine a site for diagnostic biopsy and, to monitor organ involvement and therapy in patients with sarcoidosis.

Keywords: imaging methods (CT, FA, ICG, MRI, OCT, RTA, SLO, ultrasound) • autoimmune disease • imaging/image analysis: clinical 
×
×

This PDF is available to Subscribers Only

Sign in or purchase a subscription to access this content. ×

You must be signed into an individual account to use this feature.

×